Abstract-Naringin has been reported to possess diverse pharmacological properties, including antiarthritic and anti-inflammatory activities. The aim of the present study was to determine the potential anti-inflammatory effect of naringin in a mouse model of carrageenan-induced pleurisy. A single dose of naringin (40 and 80 mg/kg) was administered per oral (p.o.) 1 h before carrageenan (Cg) administration. Pro-and anti-inflammatory cytokines were analysed in pleural fluid. We also assessed the effects of naringin on the expression levels of iNOS, inducible cyclooxygenase isoform (COX-2), ICAM-1, MIP-2, PGE2, STAT3, TGF-β1, nuclear factor kappa B (NF-κB) and inhibitor of kappa B (IκBα) in lung tissue. The histological examinations revealed anti-inflammatory effect of naringin while Cg group deteriorated. Naringin downregulated Th1 and upregulated Th2 cytokines. Western blot analyses revealed increased protein expression of NF-κB, STAT3 and COX-2 and decreased IκBα in response to Cg treatment, which were reversed by the treatment with naringin. In the Cg group, mRNA expression levels of pro-inflammatory mediators upregulated and anti-inflammatory mediators downregulated. Naringin reversed these actions.
INTRODUCTION
Flavonoids comprise a large group of naturally occurring compounds that are widely distributed in the plant kingdom, and they are found in a variety of food products, such as fruits, vegetables, nuts, seeds and beverages. Several studies have addressed the anti-oxidative, tissueprotective and tumouristatic effects of flavonoids [1, 2] .
Flavonoids have also been shown to have antiinflammatory activities [3] . The flavonoid structure consists of flavones, catechins, anthocyanidines, isoflavones, dihydroflavonols and chalcones. Naringin is a type of bioflavonoid derived from grapefruit and related citrus species [3] . Naringin and its metabolite naringenin have been reported to possess diverse biological and pharmacological properties, including anti-carcinogenic, lipidlowering, anti-apoptotic and anti-oxidant activities [4] [5] [6] . Naringin has recently received considerable attention as an anti-oxidant dietary supplement, and growing evidence has indicated that naringin display anti-inflammatory effects both in vitro and in vivo [7] We have also recently reported that naringin has anti-arthritic activity [8] .
Carrageenan is a high-molecular-weight sulphated polysaccharide that is used in pharmacology to induce local inflammation (paw oedema and pleurisy). It is a pro-inflammatory polysaccharide that is useful to assess the contribution of mediators involved in vascular changes associated with acute lung inflammation, which is an important component of a number of pulmonary diseases [9] . Carrageenan (Cg) injection into the pleural space leads to pleurisy, which is characterised by immediate neutrophil infiltration, followed by the replacement of neutrophils by macrophages and lung injury. In Cg-induced pleurisy, the initial phase of inflammation (oedema, 0-1 h) has been attributed to the release of histamine, 5-hydroxytryptamine and bradykinin, followed by a late phase (1-6 h) that is primarily sustained by prostaglandin and pro-inflammatory cytokine release [10] .
Cytokines are soluble polypeptide mediators released by many cell types including those involved in regulating immune responses. Pro-inflammatory cytokines, such as interleukin (IL)-6 and IL-1, are produced to mediate and/ or amplify their effects in peripheral organs [11] . During the acute inflammatory process, overproduction of TNF-α is crucial to the induction of inflammatory genes and the recruitment and activation of host immune cells [12] . T helper 17 (Th17) cells secrete IL-17A, a pro-inflammatory cytokine that has been linked to the pathogenesis of autoimmune diseases and immune responses to bacterial and fungal infections [13] . IL-10 is the most important antiinflammatory cytokine in the immune response. IL-10 inhibits monocyte/macrophage-derived TNF-α, IL-1β, IL-6, IL-8 and IL-12 [14] . Furthermore, the inflammatory response is mediated by various signalling molecules and enzymatic pathways, among which inducible cyclooxygenase isoform (COX-2) is a key enzyme playing an important role in regulating the formation of prostaglandins (PGs) from arachidonic acid during inflammation [15] .
Nuclear factor kappa B (NF-κB) plays an important role in the promotion of acute inflammation. It regulates the expression of many genes involved in inflammation such as inducible enzymes, chemokines and cytokines [16] . Inhibitor of kappa B (IκBα) is a critical regulator of the transcription factor NF-κB, which induces expression of a wide range of genes involved in immune and inflammatory responses, cell proliferation and apoptosis [17] . Deregulation of IκBα cellular levels and localisation results in a variety of diseases, including chronic inflammatory disorders and many types of cancer and leukaemia [18] . Signal transducer and activator of transcriptions (STATs) are often activated by members of the signal transducer activator of transcription Janus kinase (JAK) family of protein-tyrosine kinases (PTKs) in response to cytokine stimulation. STAT3, a well characterized 92-kDa protein, has been shown to become activated by both epidermal growth factor and IL-6 in human A-431 cells [19] .
The effects of the naringin treatment were confirmed by histological investigation of lung tissue. This study was also conducted to assess the effect of naringin on levels of Th1 (IL-2, IL-6, TNF-α and IL-17) and Th2 (IL-4 and IL-10) cytokines in pleural fluid using enzyme-linked immunosorbent assay (ELISA). NF-κB p65, IκBα, STAT3 and COX-2 were also demonstrated in lung tissue using Western blot analysis. We also assessed the effects of naringin on the messenger RNA (mRNA) expression levels of proinflammatory (inducible nitric oxide synthase (iNOS), COX-2, intracellular cell adhesion molecule-1 (ICAM-1), macrophage inflammatory protein-2 (MIP-2), prostaglandin E2 (PGE2), STAT3) and anti-inflammatory (TGF-β1) mediators in lung tissue.
MATERIALS AND METHODS

Animals
Female adult Balb/c mice that were 6-7 weeks old and weighed 20-22 g were acquired from the animal house of the College of Pharmacy at King Saud University, Riyadh, Kingdom of Saudi Arabia. They were maintained at a room temperature of 22± 2°C with a 12-h light/dark cycle, and mice were housed in a specific pathogen-free environment and fed standard rodent chow and water ad libitum. All procedures were performed with the approval of the Institutional Animal Care and Use Committee.
Chemicals
Naringin, heparin and λ-carrageenan were obtained from Sigma-Aldrich, USA. Mouse Th1 and Th2 ELISA kits were obtained from QIAGEN Inc., USA. The primers used in the current study for gene expression were purchased from Applied Biosystems (Paisley, UK) and Genscript (Piscataway, USA). High-Capacity cDNA Reverse Transcription kit and SYBR® Green PCR Master Mix were purchased from Applied Biosystems (Paisley, UK). TRIzol were purchased from Life Technologies (Grand Island, USA). Primary and secondary antibodies used for Western blotting were obtained from Santa Cruz (Dallas, USA). Nitrocellulose membrane was purchased from Bio-Rad Laboratories (Hercules, USA). Chemiluminescence Western blot detection kits were obtained from GE Healthcare Life Sciences (Piscataway, USA).
Experimental Design
The mice were acclimatised for 7 days and divided into four groups of six mice each, as follows: saline group, treated with sterile saline [per oral (p.o.)]; Cg group, mice were subjected to Cg-induced pleural and lung inflammation; Cg + naringin group, mice received a dose of naringin (40 mg/kg, p.o.) 1 h prior to Cginduced pleurisy; and Cg + naringin group, mice were received a dose of naringin (80 mg/kg, p.o.) 1 h prior to Cg-induced pleurisy. The doses of naringin were selected based on the results of our previous in vivo study [8] .
Cg-Induced Pleurisy
Pleurisy was induced through a single intrapleural (i.pl.) injection of 0.1-ml sterile saline and λ-carrageenan (1 %) on the right side of the chest [20] . After pleurisy induction (4 h), the animals were anesthetised with an overdose of ether, the thorax was opened, and the pleural cavity was washed with 1.0 ml of sterile phosphatebuffered saline. The histological examination was demonstrated in lung tissue. Pleural fluid were collected for the determination of Th1 and Th2 cytokine levels, and mRNA expression levels of pro-and anti-inflammatory mediators were assessed in the lung tissue. NF-κB p65, IκBα, STAT3 and COX-2 were also demonstrated in lung tissue using Western blot analysis.
Histological Examination
Lung tissue samples were taken at 4 h after injection of Cg. They were fixed for 1 week in buffered formaldehyde solution (10 % in phosphate-buffered saline (PBS)) at room temperature, dehydrated by graded ethanol and embedded in paraplast (Sherwood Medical, Mahwah, NJ). Tissue sections (thickness 7 μm) were deparaffinised with xylene, stained with haematoxylin and eosin (H&E) stains studied using light microscopy (Dialux 22 Leitz, Milan, Italy). The following morphological criteria were used for scoring: 0, normal lung; grade 3, minimal oedema or infiltration of alveolar or bronchiolar walls; grade 5, inflammatory cell infiltration with lobar lung pneumonia, alveolar septum and occasional obliterated alveoli with obvious damage to lung architecture; grade 7, severe inflammatory cell infiltration with obvious damage to lung architecture [21] . All the histological studies were performed in a blinded fashion on a 0-10 scale to avoid scoring biases.
Quantification of Th1 and Th2 Cytokines
Pleural fluid samples were obtained from all animals including the normal controls (treated with sterile saline) and immediately prepared for the analysis of cytokine levels. Commercially available kits were used with monoclonal antibodies specific for each cytokine. The cytokine levels were measured with an ELISA kit (Ray Biotech Inc., USA) according to the manufacturer's instructions. Briefly, individual samples were added in triplicate to 96-well plates that had been coated with anti-cytokine capture antibody. After overnight incubation, the plates were washed extensively, and biotinylated anti-cytokine detection antibodies were added, followed by incubation at room temperature for 2 h. Bound antibodies were detected using horseradish peroxidase (HRP)-conjugated streptavidin and visualised using tetramethylbenzidine (TMB) substrate, followed by absorbance determination at 450 nm. The individual recombinant cytokines provided in the kits were used to establish standard curves [22] .
Western Blot Analysis of NF-κB p65, IκBα, STAT3 and COX-2
Protein extraction from lung tissue was performed as previously described [23] . Briefly, lungs were washed with cold PBS, cut into small pieces and homogenised separately in cold protein lysing buffer [24] . Total cellular protein was obtained by incubating the cell lysates on ice for 1 h, with intermittent vortex mixing every 10 min, followed by centrifugation at 12,000×g for 10 min at 4°C. Western blot analysis was performed as previously described [25] . Briefly, 25-50 μg of protein from each treatment group was separated by 10 % sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (PAGE) and then electrophoretically transferred to nitrocellulose membrane. Protein blots were then blocked overnight at 4°C, followed by incubations with a primary mouse monoclonal NF-κB p65, IκBα, STAT3 and COX-2 antibody and then anti-mouse peroxidase-conjugated secondary antibody at room temperature. The NF-κB p65, IκBα, STAT3 and COX-2 bands were visualized using the enhanced chemiluminescence method (GE Healthcare, Mississauga, ON), and then quantified relative to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) bands using ImageJ® image processing program (National Institutes of Health, Bethesda, MD). Images were taken on CDiGit chemiluminescent Western blot scanner (LI-COR Biosciences, USA).
RNA Extraction and cDNA Synthesis
All the extraction procedures were performed on ice using ice-cold reagents. Total RNA from lung tissue from each mouse homogenate was isolated using TRIzol reagent (Invitrogen). The isolation method was performed according to the manufacturer's instructions and quantified by measuring the absorbance at 260 nm; the RNA quality was determined by measuring the 260:280 ratio. Complementary DNA (cDNA) synthesis was performed using a HighCapacity cDNA Reverse Transcription kit (Applied Biosystems) according to the manufacturer's instructions. Briefly, 1.5 μg of total RNA from each sample was added to a mixture of 2.0 μl of 10× reverse transcriptase buffer, 0.8 μl of 25× dNTP mix (l00 mM), 2.0 μl of l0× reverse transcriptase random primers, 1.0 μl of MultiScribe reverse transcriptase and 3.2 μl of nuclease-free water. The final reaction mixture was kept at 25°C for 10 min, heated to 37°C for 120 min, heated at 85°C for 5 s and finally cooled to 4°C [26] .
Quantification of mRNA Expression
A quantitative analysis of the mRNA expression of target genes was performed using RT-PCR with reverse-transcribed cDNA in 96-well optical reaction plates on an ABI Prism 7500 System (Applied Biosystems). The 25-μl reaction mixture contained 0.1 μl of 10 μM forward primer and 0.1 μl of 10 μM reverse primer (40-μM final concentration of each primer), 12.5 μl of SYBR Green Universal Master Mix, 11.05 μl of nuclease-free water and 1.25 μl of cDNA sample. The primers used in the current study were selected from PubMed databases, as listed in Table 1 . Assay controls were incorporated on the same plate, including no-template controls to test for the contamination of assay reagents. The real-time PCR data were analysed using the relative gene expression (i.e. ΔΔCT) method, as described in Applied Biosystems User Bulletin No. 2. Briefly, the data were presented as the fold change in gene expression normalised to the endogenous reference gene (GAPDH) and relative to a calibrator [27] .
Statistical Analysis
All values in the figures and text are expressed as the mean±standard error (S.E.M) of n observations. For the in vivo studies, n represents the number of animals studied. The results were analysed with ANOVA followed by Tukey-Kramer for comparisons between groups. p<0.05 was accepted as a significant difference between each pair of compared groups.
RESULTS
Effect of Naringin on Cg-Induced Pleurisy Figure 1 shows patent alveolar structure of lung sections of healthy mice from saline group. Cg-treated animals showed lung sections with dense inflammation obliterated alveoli, thickened alveolar septum, patchy pneumonia and blood cell extravasation. Naringin (40 and 80 mg/kg) revealed a significant improvement in the lung sections, and the overall examination of the sections showed much less inflammatory areas, few patches of congestive stage and wider areas of healing features of patent alveoli with less infiltration of inflammatory cells with much less appearance of pneumonia or emphysema.
Effects of Naringin on Th1 and Th2 Cytokine Levels
Activation of pro-inflammatory cytokines is the key mediator of the inflammatory process and leads to consequent inflammatory impairment. The levels of IL-2, IL-6 and TNF-α increased in the pleural fluid of animals with Cg-induced pleurisy compared with the saline control group. The release of these proinflammatory cytokines was significantly attenuated by treatment with naringin ( Fig. 2a-c) . Naringin (40 and 80 mg/kg) led to a significant decrease in all the tested cytokines at 4 h compared with Cg group. Remarkably, Cg significantly increased the levels of IL-17 compared to the saline control group, and the treatment of mice with naringin reduced IL-17 cytokine level in the pleural fluid compared to the Cg group (Fig. 2d) . As shown in Fig. 3a , b, Cg-treated group significantly downregulated in IL-4 and IL-10 cytokine levels compared to the saline control group. In contrast, naringin (40 and 80 mg/kg) upregulated IL-4 and IL-10 cytokine levels compared to Cg group.
Effect of Naringin on NF-κB p65, IκBα, STAT3 and COX-2 Protein Expression
We measured the quantification of NF-κB p65, IκBα, STAT3 and COX-2 by Western blot analysis to examine the cellular and molecular mechanisms responsible for mediating the anti-inflammatory effects of naringin. Level of NF-κB p65 level in the lung tissue was significantly increased at 4 h after Cg injection compared to the saline control group. Naringin significantly reduced the activation of NF-κB p65, as shown in Fig. 4 . Furthermore, IκBα was , and the histopathological examinations were analysed at 4 h after carrageenan injection. b The histological score was made by an independent observer. Statistical analysis was performed using a one-way ANOVA followed by the Tukey-Kramer post-test. Each value indicates the mean±S.E.M of six animals. *p<0.05 is accepted as the level of significance) compared to the saline (−ve control) group; a compared to the Cg (+ve control) group. F 5′-CTATGGCCGCTTTGATGTGC-3′, R 5′-CAACCTTGGTGTTGAAGGCG-3′ F 5′-CACTCATGAGCAGTCCCCTC-3′, R 5′-ACCCTGGTCGGTTTGATGTT-3′ F 5′-GCGGAGTCCGGGCAGGTCTA-3′, R 5′-GGGGGCTGGCTCTGTGAGGA-3′ F 5′-CCAAGGGTTGACTTCAAGAAC-3′, R 5′-AGCGAGGCACATCAGGTACG-3′ F 5′-CATGCTGGACGAGAAGGAGG-3′, R 5′-TCTTTACCCACGGCTGTCAC-3′ F 5′-CCCCCGTACCTGAAGACCAAG-3′, R 5′-TCCTCACATGGGGGAGGTAG-3′ F5′-CACCGGAGAGCCCTGGATA-3′, R 5′-TGCCGCACACAGCAGTTC-3′ F 5′CCCAGCAAGGACACTGAGCAAG-3′, R 5′GGTCTGGGATGGAAATTGTGAGGG-3′
iNOS inducible nitric oxide synthase, COX-2 cyclooxygenase-2, ICAM-1 intracellular cell adhesion molecule-1, MIP-2 macrophage inflammatory protein-2, PGE2 prostaglandin E2, STAT3 signal transducer and activator of transcription 3, TGF-β1 transforming growth factor beta-1, GAPDH glyceraldehyde 3-phosphate dehydrogenase detected in lung samples from Cg-treated animals, whereas IκBα level was substantially reduced in lung tissue obtained from Cg group. Naringin (40 and 80 mg/kg) treatment prevented IκBα degradation (Fig. 4) . A significant increase in STAT3 and COX-2 protein levels were detected in lung tissue isolated from mice in the Cg-injected group (Fig. 5) . Striki n gl y, t r e at m e nt w it h n a r i ng i n ( 8 0 m g / kg )
significantly reduced Cg-induced expression of STAT3 and COX-2 (Fig. 5) .
Effect of Naringin on iNOS, COX-2, ICAM-1 and MIP-2 mRNA Expression
At 4 h after Cg injection, the lung tissue obtained from Cg group substantially increased mRNA expression levels of iNOS, COX-2, ICAM-1 and MIP-2, as shown in Fig. 6a-d) . In contrast, the mRNA expression levels of these pro-inflammatory mediators were significantly lower in naringin-treated (40 and 80 mg/kg) mice ( Fig. 6a-d) .
Effect of Naringin on PGE2 and STAT3 mRNA Expression
PGE2 is one of the most abundant PGs produced in the body, most widely characterised in animal species and exhibits versatile biological activities. Cg group significantly increased PGE2 and STAT3 mRNA expression. In contrast, naringin (40 and 80 mg) completely prevented these inductions and downregulated PGE2 and STAT3 mRNA expression levels (Fig. 7a, b) .
Effect of Naringin on TGF-β1 mRNA Expression
TGF-β is a pleiotropic cytokine that controls cell growth and differentiation. Within the immune system, TGF-β inhibits the growth of T cells, B cells and other hematopoietic cells and suppresses interferon gamma (IFN-γ) production. The Cg-treated group exhibited marked downregulation of transforming growth factor beta-1 (TGF-β1) compared with the saline group, whereas naringin (40 and 80 mg/kg) augmented TGF-β1 mRNA expression level compared with the Cg control group (Fig. 8) .
DISCUSSION
Recently, growing evidence has indicated that naringin displays anti-inflammatory and anti-arthritic effects both in vitro and in vivo [28, 8] . An in vitro study using RAW264.7 cells showed that naringin inhibited the LPS-induced production of nitric oxide by suppressing the activation of NF-κB [28] . Naringin repressed the PI3K/Akt/mTOR/p70S6K pathway, invasion and migration and subsequently inhibited MMP-9 expression through the transcription factors NF-κB and activator protein-1 in TNF-α-induced vascular smooth muscle cells (VSMCs) [29] . However, there is no information regarding the effects of naringin on Cg-induced inflammation in a mouse model. Therefore, we hypothesised that naringin plays a pivotal role in inflammation and may inhibit Th1 cytokines levels, pro-inflammatory mediator expression and molecular mechanisms responsible for mediating the anti-inflammatory effects.
The results of our study highlight the complex network of cytokines that contribute to the initiation and maintenance of inflammation. Pro-inflammatory cytokines, such as TNF-α, IL-6 and INF-γ, are the key mediators of the inflammatory process and lead to consequent inflammatory impairment [30] . There are evidences that the pro-inflammatory cytokines TNF-α, IL-1β, IL-6 and IFN-γ help to propagate the extension of a local or systemic inflammatory process [31] . These proinflammatory cytokines are related to the stimulation of cellular chemotaxis and induce the expression of adhesion molecules [32] . Moreover, TNF-α, IL-1β, IL-6 and IFN-γ can also release pro-inflammatory mediators, such as nitric oxide, bradykinin, histamine and/or substance P, at the site of inflammation [33] . Activated inflammatory cells synthesise and secrete pro-inflammatory cytokines, such as TNF-α, IL-1β and IL-17A [34] . Suppressing these proinflammatory mediators has been found to reduce the severity of the inflammatory reaction [35] .
In the present study, we demonstrated that treatment with naringin could protect mice from Cg inflammation by potently inhibiting the production of pro-inflammatory cytokines. In addition, our study investigates the immunological aspect of the modulation of Cg-induced pleurisy by naringin. The results demonstrated that the inflammatory process caused by the administration of Cg in the pleural cavity led to a substantial increase in the levels of the Th1 cytokines IL-2, IL-6, TNF-α and IL-17 cytokines in the pleural fluid, and these levels were significantly lower in the pleural fluid obtained from naringin-treated animals, whereas naringin stimulated the secretion of the Th2 cytokines IL-4 and IL-10 in pleural fluid compared to the Cg group. IL-17 has been postulated to play a pivotal role in the inflammatory process because it is able to stimulate the synthesis of other pro-inflammatory cytokines, such as TNF-α, IL-1β and IL-6, and prostaglandins [36] . Furthermore, IL-17 is a critical mediator of neutrophil recruitment and migration [37] . However, the present study showed that the anti-inflammatory activity of naringin in the mouse model of pleurisy can be explained through the reduction of Th1 cytokine and IL-17 levels concomitant with an increase in Th2 cytokines at the site of inflammation. IL-10 has strong immunosuppressive activity mediated through the downregulation of pro-inflammatory cytokines, MHC class II molecules and T cell-mediated inflammatory responses, including delayed hypersensitivity and Th2-driven allergic responses [38] . IL-4 appears to exhibit some anti-inflammatory properties by inhibiting the production of several pro-inflammatory cytokines such as IL-1, IL-6, IL-8 and TNF-α, by synovial membranes of rheumatoid arthritis patients [39] . The histological examinations in our studies discovered the anti-inflammatory effects of naringin treatment, whereas Cg worsens the inflammation. Cumulative indication recommends that naringin treatment contributes in Cg-induced inflammation in the pleural and lung tissue. In this study, we also observed that Cg injection produced a substantial increase in the NF-κB activation in the lung tissue at 4 h after Cg injection, whereas naringin treatment significantly downregulated the NF-κB activation and inhibited the IκBα degradation. NF-κB is known to be a major transcription factor that regulates the gene expression of pro-inflammatory mediators which participate in the inflammatory response [40] . NF-κB proteins exist normally in the cytoplasm as an inactive complex by binding to inhibitory factor, IκBα, thereby blocking NF-κB nuclear translocation. Upon stimulation with inflammatory stimuli, IκBα is phosphorylated by IκB kinase (IKK) and separated from the NF-κB subunits which lead to its degradation. In the nucleus, NF-κB dimers combine with target DNA elements to activate transcription of genes encoding for proteins involved in inflammation [41] . In inflammation, activated NF-κB regulates transcription of IL-1β, IL-6, iNOS, COX-2 and TNF-α [42] .
In accordance with these findings, to further elucidate the mechanism underlying the preventive action of naringin on lung tissue, we examined the mRNA expression levels of inflammatory mediators in lung tissue using RT-PCR. The mRNA levels of iNOS, COX-2, ICAM-1 and MIP-2 were significantly increased in the Cg-treated group, whereas treatment with naringin attenuated the mRNA transcription of these pro-inflammatory mediators. The activation of iNOS catalyzes the formation of a large amount of NO, which plays a key role in the pathogenesis of a variety of inflammatory diseases [43] . For instance, inhibitors of NOS activity reduce the development of Cg-induced inflammation [44] . COX-2 induction is responsible for the enormous increase in PGE2 which is a critical regulator for many cell functions. The eukaryotic transcription factor NF-κB is a critical regulator of COX-2 expression [45] . ICAM-1 adhesive interactions are critical for the transendothelial migration of leukocytes and the activation of T cells where ICAM-1 binding functions as a co-activation signal [46] . ICAM-1 is also associated with a variety of inflammatory diseases and conditions including asthma, atherosclerosis, inflammatory bowel disease and autoimmune disease [47] . MIP-2 is a major CXC chemokine involved in the migration of PMNs to the sites of inflammation. It is elicited that all PMNs produce large amounts of MIP-2 [48] , but rather lesser amounts of TNF-α and PGE2. Monocytes/macrophages are the main sources of these chemokines as well as TNF-α and PGE2 [49] . We demonstrate here that the increase in the expression levels of PGE2 and STAT3 caused by injection of Cg into the lung tissue is reduced by naringin treatment. Dysregulated PGE2 synthesis or degradation has been associated with a wide range of pathological conditions [50] . In inflammation, PGE2 is of particular interest because it is involved in all processes leading to the classic signs of inflammation: redness, swelling and pain [51] . Recent study indicated that STAT3 is activated in the lung following acute lung injury [52] . Moreover, Gao and colleagues reported that STAT3 protein synthesis in rat lungs after tissue injuries was induced by IgG immune complexes. They also showed that STAT3 activation is dependent on the presence of macrophages, neutrophils and cytokines [52] . Thus, we further propose that the reduction of PGE2 and STAT3 expressions in the lung tissue contribute to the observed anti-inflammatory properties of naringin.
TGF-β1 plays a critical role in immune regulation, behaving as a potent anti-inflammatory cytokine [53] and suppressing the production of TNF-α and IL-1β [54] . In contrast to inflammatory cytokine expression, the mRNA levels of the anti-inflammatory cytokine TGF-β1 were significantly downregulated in Cg-treated group, whereas treatment with naringin significantly upregulated the mRNA expression levels of TGF-β1. These results suggest that naringin effectively modulates anti-inflammatory cytokines to accelerate the repair process in lung inflammation and inhibits the infiltration of inflammatory cells to the damaged area through downregulating chemokines and cytokines. Our results show that naringin not only induces its anti-inflammatory effect via readjusting the delicate balance between pro-inflammatory and anti-inflammatory cytokine release but that it also affects these cytokine balances at the gene expression level. This clearly suggests that naringin has anti-inflammatory effects and could have potential therapeutic application for the treatment of inflammatory diseases.
CONCLUSION
This study demonstrates the inflammatory response induced by injection of Cg in the pleural cavity of mice is significantly attenuated by the treatment with naringin. Naringin downregulated Th1 and upregulated Th2 cytokine levels in pleural fluid. Naringin also increased IκBα degradation and attenuating NF-κB activation in lung tissue. Naringin treatment as well downregulated pro-inflammatory and upregulate the expression of antiinflammatory mediators in lung tissue, which finally may lead to the decrease of tissue injury. Taken together, these results of the present study enhance our understanding of the role of the naringin in the pathophysiology of the inflammation and support its therapeutic potential for lung inflammatory.
